Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

F-star Signs Third Collaboration with Takeda; This One is Worth up to $1 Billion

publication date: Jul 5, 2023

F-star Therapeutics, a London invoX company, formed a collaboration and license agreement with Japan’s Takeda to develop Fcab domains aimed at undisclosed immuno-oncology targets. F-star will use its proprietary fully-human Fcab™ and tetravalent mAb² platforms to identify and develop next-gen multi-specific immunotherapies. It will receive an undisclosed upfront payment, research funding and up to $1 billion in milestones from Takeda for several programs, plus royalties. F-star’s platform develops tetravalent (2+2) bispecific antibodies. invoX is the ex-China drug development arm of Sino Biopharm. More details....

Stock Symbol: (HK: 1177)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital